Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy

Abstract This study was conducted to assess whether levetiracetam (LEV) affects the survival of patients with glioblastoma (GBM) treated with concurrent temozolomide (TMZ) chemotherapy. To this end, from 2004 to 2016, 322 patients with surgically resected and pathologically confirmed isocitrate dehy...

Full description

Saved in:
Bibliographic Details
Main Authors: Tae Hoon Roh, Ju Hyung Moon, Hun Ho Park, Eui Hyun Kim, Chang-Ki Hong, Se Hoon Kim, Seok-Gu Kang, Jong Hee Chang
Format: article
Language:EN
Published: Nature Portfolio 2020
Subjects:
R
Q
Online Access:https://doaj.org/article/c2151e0ede9f40f5bc078c0b974e815f
Tags: Add Tag
No Tags, Be the first to tag this record!